Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial
Objective. This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods. ACS patients scheduled to undergo PCI (...
Main Authors: | Shuai Zhao, Yong Tang, Hairong Cai, Weifeng Liu, Lieyuan Zhang, Dongjie Chen, Bojun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/8485472 |
Similar Items
-
Systems Pharmacology-Based Approach to Comparatively Study the Independent and Synergistic Mechanisms of Danhong Injection and Naoxintong Capsule in Ischemic Stroke Treatment
by: Junfeng Zhu, et al.
Published: (2019-01-01) -
Systematical Identification of the Protective Effect of Danhong Injection and BuChang NaoXinTong Capsules on Transcription Factors in Cerebral Ischemia Mice Brain
by: Jing Xu, et al.
Published: (2020-01-01) -
Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
by: Gao Huanjia, et al.
Published: (2021-05-01) -
Specific DNA identification of Pheretima in the Naoxintong capsule
by: Xiaoxiao Zhu, et al.
Published: (2019-09-01) -
Protective effects of Naoxintong Capsule on rats with blood stasis syndrome
by: Wei-jian Zhang, et al.
Published: (2020-01-01)